Self-sampling device to be sent automatically, making it easier to take part in cervical cancer screening From the first week of July, every woman turning 30 will receive a self-sampling device with their invitation for cervical cancer screening. Participants can use this device to collect their own vaginal material.
No major change in air quality in the Netherlands in 2022 The overall air quality in 2022 was slightly worse than in 2021. Weather conditions such as temperature and drought played an important role in this difference. This is according to the large-scale concentration maps published by RIVM each year.
More reports of adverse effects of implants in 2019 In 2019, the Dutch reporting centre for adverse effects of medical implants (MEBI) received 397 reports of suspected adverse effects. The reports concerned 462 implants.
Excess mortality decreasing, now also in nursing- and care homes The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers that RIVM publishes daily.
COVID-19 in nursing homes It is estimated that about one-third of nursing homes in the Netherlands have at least one patient with COVID-19.
Excess mortality caused by the novel coronavirus (COVID-19) The actual number of deaths from the novel coronavirus in the Netherlands is higher than the reported numbers published by RIVM.
Regional differences in the coronavirus epidemic There are significant regional differences in the coronavirus epidemic in the Netherlands.
Mental care still the most expensive of all In 2011, 19.6 billion euros was spent on the treatment of mental disorders. This amounted to 22% of the total expenditure on health and welfare during that year.
Risks of eHealth technology RIVM and Nictiz have made an overview of the risks that eHealth applications may entail and how these risks can be controlled.
Key organisations unite to improve benefit and risk assessments of vaccines Leading organisations have joined forces to launch a unique project that will pave the way for a pan-European framework for rapidly assessing and communicating the benefits and risks of vaccines.